Vitamin A deficiency and behavioral and motor deficits in the human immunodeficiency virus type 1 transgenic rat

Journal of NeuroVirology

Volumn 15, Issue 5-6, 2009, Pages 380-389

  June, Harry L ^a   Tzeng Yang, Andrew Rong Song ^a   Bryant, Joseph L ^a   Jones, Odell ^a   Royal, Walter ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

HIV 1; Open field; Retinoids; Rotarod; Transgenic rat; Vitamin A

Indexed keywords

RETINOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR DISORDER; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN IMMUNODEFICIENCY VIRUS 1; MOTOR DYSFUNCTION; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; RAT; REARING; RETINOL DEFICIENCY; ROTAROD TEST; TRANSGENIC RAT; VIRUS GENOME; WILD TYPE;

AIDS DEMENTIA COMPLEX; ANIMALS; BEHAVIOR, ANIMAL; COGNITION; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; FEMALE; GENOME, VIRAL; HIV-1; MALE; MOTOR ACTIVITY; MOTOR SKILLS DISORDERS; POSTURAL BALANCE; RATS; RATS, INBRED F344; RATS, TRANSGENIC; SEVERITY OF ILLNESS INDEX; TRANSGENES; VITAMIN A DEFICIENCY;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS 1; RATTUS; RODENTIA;

EID: 77649161229     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550280903350200     Document Type: Article

References (51)

1. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007). Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69: 1789-1799.
2. Bansal AK, Mactutus CF, Nath A, Maragos W, Hauser KF, Booze RM (2000). Neurotoxicity of HIV-1 proteins gp120 and Tat in the rat striatum. Brain Res 879: 42-49.
3. Caldecott-Hazard S, Mazziotta J, Phelps M (1988). Cerebral correlates of depressed behavior in rats, visualized using 14C-2-deoxyglucose autoradiography. J Neurosci 8: 1951-1961.
4. Carman JA, Hayes CE (1991). Abnormal regulation of IFN-gamma secretion in vitamin A deficiency. J Immunol 147: 1247-1252.
5. Carta M, Stancampiano R, Tronci E, Collu M, Usiello A, Morelli M, Fadda F (2006). Vitamin A deficiency induces motor impairments and striatal cholinergic dysfunction in rats. Neuroscience 139: 1163-1172.
6. Cedeno-Laurent F, Bryant J, Fishelevich R, Jones OD, Deng A, Eng ML, Gaspari AA, Trujillo JR (2009). Inflammatory papillomatous hyperplasia and epidermal necrosis in a transgenic rat for HIV-1. J Dermatol Sci 53: 112-119.
7. Cocco S, Diaz G, Stancampiano R, Diana A, Carta M, Curreli R, Sarais L, Fadda F (2002). Vitamin A deficiency produces spatial learning and memory impairment in rats. Neuroscience 115: 475-482.
8. Corcoran J, So PL, Maden M (2002). Absence of retinoids can induce motoneuron disease in the adult rat and a retinoid defect is present in motoneuron disease patients. J Cell Sci 115: 4735-4741.
9. EtchamendyN,EnderlinV,MarighettoA,PalletV,HigueretP, JaffardR(2003). VitaminAdeficiency and relational memory deficit in adult mice: relationships with changes in brain retinoid signalling. Behav Brain Res 145: 37-49.
10. Fawzi WW, Msamanga G, Hunter D, Urassa E, Renjifo B, Mwakagile D, Hertzmark E, Coley J, Garland M, Kapiga S, Antelman G, Essex M, Spiegelman D (2000). Randomized trial of vitamin supplements in relation to vertical transmission of HIV-1 in Tanzania. J Acquir Immune Defic Syndr 23: 246-254.
11. Frye GD, Breese GR (1981). An evaluation of the locomotor stimulating action of ethanol in rats and mice. Psycho-pharmacology (Berl) 75: 372-379.
12. Greenberg BL, Semba RD, Vink PE, Farley JJ, Sivapalasingam M, Steketee RW, Thea DM, Schoenbaum EE (1997). Vitamin A deficiency and maternal-infant transmissions of HIV in two metropolitan areas in the United States. AIDS 11: 325-332.
13. Hudson L, Liu J, Nath A, Jones M, Raghavan R, Narayan O, Male D, Everall I (2000). Detection of the human immunodeficiency virus regulatory protein tat in CNS tissues. J NeuroVirol 6: 145-155.
14. Humphrey JH, Iliff PJ, Marinda ET, Mutasa K, Moulton LH, Chidawanyika H, Ward BJ, Nathoo KJ, Malaba LC, Zijenah LS, Zvandasara P, Ntozini R, Mzengeza F, Mahomva AI, Ruff AJ, Mbizvo MT, Zunguza CD (2006). Effects of a single large dose of vitamin A, given during the postpartum period to HIV-positive women and their infants, on child HIV infection, HIV-free survival, and mortality. J Infect Dis 193: 860-871.
15. Janssen RS, Cornblath DR, Epstein LG, McArthur J, Price RW (1989). Human immunodeficiency virus (HIV) infection and the nervous system: report from the American Academy of Neurology AIDS Task Force [review]. Neurology 39: 119-122.
16. Kehne JH, Sant WW, Sorenson CA (1981). The effects of radio-frequency lesions of the nucleus accumbens on D-amphetamine-induced locomotor and rearing behavior in rats. Psychopharmacology (Berl) 75: 363-367.
17. Kitano K, Baldwin GC, Raines MA, Golde DW (1990). Differentiating agents facilitate infection of myeloid leukemia cell lines by monocytotropic HIV-1 strains. Blood 76: 1980-1988.
18. Kralic JE, Wheeler M, Renzi K, Ferguson C, O'Buckley TK, Grobin AC, Morrow AL, Homanics GE (2003). Deletion of GABAA receptor alpha 1 subunit-containing receptors alters responses to ethanol and other anesthetics. J Pharmacol Exp Ther 305: 600-607.
19. Krezel W, Dupe V, Mark M, Dierich A, Kastner P, Chambon P (1996). RXR gamma null mice are apparently normal and compound RXR alpha +/- /RXR beta -/-/RXR gamma -/- mutant mice are viable. Proc Natl Acad Sci USA 93: 9010-9014.
20. Krezel W, Ghyselinck N, Samad TA, Dupe V, Kastner P, Borrelli E, Chambon P (1998). Impaired locomotion and dopamine signaling in retinoid receptor mutant mice. Science 279: 863-867.
21. Lashomb AL, Vigorito M, Chang SL (2009). Further characterization of the spatial learning deficit in the human immunodeficiency virus-1 transgenic rat. J NeuroVirol 15: 14-24.
22. Lee MO, Hobbs PD, Zhang XK, Dawson MI, Pfahl M (1994). A synthetic retinoid antagonist inhibits the human immunodeficiency virus type 1 promoter. Proc Natl Acad Sci USA 91: 5632-5636.
23. Lister RG (1987). The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berl) 92: 180-185.
24. Liu Y, Kagechika H, Ishikawa J, Hirano H, Matsukuma S, Tanaka K, Nakamura S (2008). Effects of retinoic acids on the dendritic morphology of cultured hippocampal neurons. J Neurochem 106: 1104-1116.
25. MacDonald KS, Malonza I, Chen DK, Nagelkerke NJ, Nasio JM, Ndinya-Achola J, Bwayo JJ, Sitar DS, Aoki FY, Plummer FA (2001). Vitamin A and risk of HIV-1 seroconversion among Kenyan men with genital ulcers. AIDS 15: 635-639.
26. Maciaszek JW, Coniglio SJ, Talmage DA, Viglianti GA (1998). Retinoid-induced repression of human immunodeficiency virus type 1 core promoter activity inhibits virus replication. J Virol 72: 5862-5869.
27. Markel AL, Galaktionov Y, Efimov VM (1989). Factor analysis of rat behavior in an open field test. Neurosci Behav Physiol 19: 279-286.
28. McKay PF, Foster KL, Mason D, Cummings R, Garcia M, Williams LS, Grey C, McCane S, He X, Cook JM, June HL (2004). A high affinity ligand for GABAA-receptor containing alpha5 subunit antagonizes ethanol's neurobehavioral effects in Long-Evans rats. Psychopharmacology (Berl) 172: 455-462.
29. Nadler JJ, Zou F, Huang H, Moy SS, Lauder J, Crawley JN, Threadgill DW, Wright FA, Magnuson TR (2006). Large-scale gene expression differences across brain regions and inbred strains correlate with a behavioral pheno-type. Genetics 174: 1229-1236.
30. Poggi SH, Park J, Toso L, Abebe D, Roberson R, Woodard JE, Spong CY (2005). No phenotype associated with established lipopolysaccharide model for cerebral palsy. Am J Obstet Gynecol 192: 727-733.
31. Poli G, Kinter AL, Justement JS, Bressler P, Kehrl JH, Fauci AS (1992). Retinoic acid mimics transforming growth factor beta in the regulation of human immunodeficiency virus expression in monocytic cells. Proc Natl Acad Sci U S A 89: 2689-2693.
32. Reid W, Abdelwahab S, Sadowska M, Huso D, Neal A, Ahearn A, Bryant J, Gallo RC, Lewis GK, Reitz M (2004a). HIV-1 transgenic rats develop T cell abnormalities. Virology 321: 111-119.
33. Reid W, Abdelwahab S, Sadowska M, Huso D, Neal A, Ahearn A, Bryant J, Gallo RC, Lewis GK, Reitz M (2004b). HIV-1 transgenic rats develop T cell abnormalities. Virology 321: 111-119.
34. Reid W, Sadowska M, Denaro F, Rao S, Foulke J Jr, Hayes N, Jones O, Doodnauth D, Davis H, Sill A, O'Driscoll P, Huso D, Fouts T, Lewis G, Hill M, Kamin-Lewis R, Wei C, Ray P, Gallo RC, Reitz M, Bryant J (2001). An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction. Proc Natl Acad Sci U S A 98: 9271-9276.
35. Royal W III, Wang H, Jones O, Tran H, Bryant JL (2007). A vitamin A deficient diet enhances proinflammatory cytokine, Mu opioid receptor, and HIV-1 expression in the HIV-1 transgenic rat. J Neuroimmunol 185: 29-36.
36. Semba RD, Caiaffa WT, Graham NM, Cohn S, Vlahov D (1995). Vitamin A deficiency and wasting as predictors of mortality in human immunodeficiency virus-infected injection drug users. J Infect Dis 171: 1196-1202.
37. Semba RD, Graham NM, Caiaffa WT, Margolick JB, Clement L, Vlahov D (1993). Increased mortality associated with vitamin A deficiency during human immunodeficiency virus type 1 infection. Arch Int Med 153: 2149-2154.
38. Semba RD, Miotti PG, Chiphangui JD, Saah AJ, Conner JK, Dallabetta GA, Hoover DR (1994). Maternal vitamin A deficiency and mother-to-child transmission of HIV-1. Lancet 343: 1593-1697.
39. Semmel M, Macho A, Coulaud D, Alileche A, Plaisance S, Aguilar J, Jasmin C (1994). Effect of retinoic acid on HL-60 cells infected with human immunodeficiency virus type 1. Blood 84: 2480-2488.
40. Summavielle T, Magalhaes A, Castro-Vale I, de Sousa L, Tavares MA (2002). Neonatal exposure to cocaine: altered dopamine levels in the amygdala and behavioral outcomes in the developing rat. Ann N Y Acad Sci 965: 515-521.
41. Tang AM, Graham NM, Kirby AJ, McCall LD, Willett WC, Saah AJ (1993). Dietary micronutrient intake and risk of progression to acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus type 1 (HIV-1)-infected homosexual men. Am J Epidemiol 138: 937-951.
42. Tang AM, Graham NM, Semba RD, Saah AJ (1997). Association between serum vitamin A and E levels and HIV-1 disease progression. AIDS 11: 613-620.
43. Taylor BK, Joshi C, Uppal H (2003). Stimulation of dopa-mine D2 receptors in the nucleus accumbens inhibits inflammatory pain. Brain Res 987: 135-143.
44. Than M, Kocsis P, Tihanyi K, Fodor L, Farkas B, Kovacs G, Kis-Varga A, Szombathelyi Z, Tarnawa I (2007). Concerted action of antiepileptic and antidepressant agents to depress spinal neurotransmission: Possible use in the therapy of spasticity and chronic pain. Neurochem Int 50: 642-652.
45. Thor S, Ericson J, Brännström T, Edlund T (1991). The homeodomain LIM protein Isl-1 is expressed in subsets of neurons and endocrine cells in the adult rat. Neuron 7: 881-889.
46. Towers G, Harris J, Lang G, Collins MK, Latchman DS (1995). Retinoic acid inhibits both the basal activity and phorbol ester- mediated activation of the HIV long terminal repeat promoter. AIDS 9: 129-136.
47. Vigorito M, Lashomb AL, Chang SL (2007). Spatial learning and memory in HIV-1 transgenic rats. J Neuroimmune Pharmacol 2: 319-328.
48. Walsh RN, Cummins RA (1976). The Open-Field Test: a critical review. Psychol Bull 83: 482-504.
49. Whimbey AE, Denenberg VH (1967). Two independent behavioral dimensions in open-field performance. J Comp Physiol Psychol 63: 500-504.
50. Yamaguchi K, Groopman JE, Byrn RA (1994). The regulation of HIV by retinoic acid correlates with cellular expression of the retinoic acid receptors. AIDS 8: 1675-1682.
51. Zetterstrom RH, Lindqvist E, Mata dU, Tomac A, Eriksson U, Perlmann T, Olson L (1999). Role of retinoids in the CNS: differential expression of retinoid binding proteins and receptors and evidence for presence of retinoic acid. Eur J Neurosci 11: 407-416.